R-HSA-109581
|
Apoptosis
|
R-HSA-111465
|
Apoptotic cleavage of cellular proteins
|
R-HSA-1266738
|
Developmental Biology
|
R-HSA-1266738
|
Developmental Biology
|
R-HSA-1500931
|
Cell-Cell communication
|
R-HSA-162582
|
Signal Transduction
|
R-HSA-162582
|
Signal Transduction
|
R-HSA-1643685
|
Disease
|
R-HSA-168249
|
Innate Immune System
|
R-HSA-168256
|
Immune System
|
R-HSA-1834949
|
Cytosolic sensors of pathogen-associated DNA
|
R-HSA-194138
|
Signaling by VEGF
|
R-HSA-194315
|
Signaling by Rho GTPases
|
R-HSA-195253
|
Degradation of beta-catenin by the destruction complex
|
R-HSA-195258
|
RHO GTPase Effectors
|
R-HSA-195721
|
Signaling by WNT
|
R-HSA-195721
|
Signaling by WNT
|
R-HSA-196299
|
Beta-catenin phosphorylation cascade
|
R-HSA-201681
|
TCF dependent signaling in response to WNT
|
R-HSA-201681
|
TCF dependent signaling in response to WNT
|
R-HSA-201722
|
Formation of the beta-catenin:TCF transactivating complex
|
R-HSA-201722
|
Formation of the beta-catenin:TCF transactivating complex
|
R-HSA-212436
|
Generic Transcription Pathway
|
R-HSA-2980736
|
Peptide hormone metabolism
|
R-HSA-3134973
|
LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production
|
R-HSA-351906
|
Apoptotic cleavage of cell adhesion proteins
|
R-HSA-3769402
|
Deactivation of the beta-catenin transactivating complex
|
R-HSA-381771
|
Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)
|
R-HSA-3858494
|
Beta-catenin independent WNT signaling
|
R-HSA-392499
|
Metabolism of proteins
|
R-HSA-400508
|
Incretin synthesis, secretion, and inactivation
|
R-HSA-4086398
|
Ca2+ pathway
|
R-HSA-418990
|
Adherens junctions interactions
|
R-HSA-421270
|
Cell-cell junction organization
|
R-HSA-4411364
|
Binding of TCF/LEF:CTNNB1 to target gene promoters
|
R-HSA-4420097
|
VEGFA-VEGFR2 Pathway
|
R-HSA-446728
|
Cell junction organization
|
R-HSA-4641262
|
Disassembly of the destruction complex and recruitment of AXIN to the membrane
|
R-HSA-4641262
|
Disassembly of the destruction complex and recruitment of AXIN to the membrane
|
R-HSA-4791275
|
Signaling by WNT in cancer
|
R-HSA-4839743
|
phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex
|
R-HSA-5218920
|
VEGFR2 mediated vascular permeability
|
R-HSA-525793
|
Myogenesis
|
R-HSA-525793
|
Myogenesis
|
R-HSA-5339716
|
Misspliced GSK3beta mutants stabilize beta-catenin
|
R-HSA-5357801
|
Programmed Cell Death
|
R-HSA-5358747
|
S33 mutants of beta-catenin aren't phosphorylated
|
R-HSA-5358749
|
S37 mutants of beta-catenin aren't phosphorylated
|
R-HSA-5358751
|
S45 mutants of beta-catenin aren't phosphorylated
|
R-HSA-5358752
|
T41 mutants of beta-catenin aren't phosphorylated
|
R-HSA-5626467
|
RHO GTPases activate IQGAPs
|
R-HSA-5663202
|
Diseases of signal transduction
|
R-HSA-5663205
|
Infectious disease
|
R-HSA-73857
|
RNA Polymerase II Transcription
|
R-HSA-74160
|
Gene expression (Transcription)
|
R-HSA-75153
|
Apoptotic execution phase
|
R-HSA-8876384
|
Listeria monocytogenes entry into host cells
|
R-HSA-8876493
|
InlA-mediated entry of Listeria monocytogenes into host cells
|
R-HSA-8878159
|
Transcriptional regulation by RUNX3
|
R-HSA-8951430
|
RUNX3 regulates WNT signaling
|
R-HSA-9006934
|
Signaling by Receptor Tyrosine Kinases
|